Research Output per year
Research Output per year
- 1 - 50 out of 328 results
Search results
-
2024
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Fehniger, T. A., Watkins, M. P., Ezenwajiaku, N., Wan, F., Hurd, D. D., Cashen, A. F., Blum, K. A., Goy, A., Fenske, T. S., Wagner-Johnston, N. D., Carson, K., Siegel, M. J., Russler-Germain, D., Schneider, S. E., Mehta-Shah, N., Kahl, B. & Bartlett, N. L., Mar 2024, In: Haematologica. 109, 3, p. 953-957 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
A Response Letter by Cameron et al
Cameron, R. B., Hines, J. B., Torri, V. & Garassino, M. C., Aug 2024, In: Journal of Thoracic Oncology. 19, 8, p. e26-e28Research output: Contribution to journal › Letter › peer-review
-
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Badar, T., Nanaa, A., Atallah, E., Shallis, R. M., Guilherme, S. D. C. C., Goldberg, A. D., Saliba, A. N., Patel, A., Bewersdorf, J. P., DuVall, A. S., Bradshaw, D., Abaza, Y., Murthy, G. S. G., Palmisiano, N., Zeidan, A. M., Kota, V. & Litzow, M. R., Dec 2024, In: Blood cancer journal. 14, 1, 32.Research output: Contribution to journal › Letter › peer-review
Open Access10 Scopus citations -
Considerations in Meta-Analysis of Immunotherapy for Advanced Cancers Other Than Melanoma - Reply
Shenoy, N. K., Apr 18 2024, In: JAMA Oncology. 10, 4, p. 536 1 p.Research output: Contribution to journal › Letter › peer-review
-
Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation
Roloff, G. W., Kosuri, S., Nawas, M. T., Vall, A. S. D., Patel, A. A., Riedell, P. A., Odenike, O., Stock, W., Larson, R. A., Bishop, M. R., Nunley, E., Godley, L. A., Hathaway, F., Gaudio, D. D., Das, S., Canham, L. E. & Drazer, M. W., 2024, In: Haematologica.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Germline loss-of-function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies
Stubbins, R. J., Asom, A. S., Wang, P., Lager, A. M., Gary, A. & Godley, L. A., Jan 2024, In: Haematologica. 109, 1, p. 351-356 6 p.Research output: Contribution to journal › Letter › peer-review
Open Access5 Scopus citations -
Local Immunoradiotherapy in Patients with Metastatic Soft-Tissue Sarcoma - Reply
Seo, Y. D. & Pollack, S. M., Jun 20 2024, In: JAMA Oncology. 10, 6, p. 830-831 2 p.Research output: Contribution to journal › Letter › peer-review
-
2023
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors
Roloff, G. W., Wen, F., Ramsland, A., Artz, A. S., Kosuri, S., Stock, W., Odenike, O., Larson, R. A., Liu, H., Godley, L. A., Thirman, M. J., Patel, A. A., Daugherty, C. K., DuVall, A. S., Nawas, M. T., Dworkin, E., Wool, G. D., Gurbuxani, S., Fitzpatrick, C. & Segal, J. P. & 2 others, , Aug 2023, In: Haematologica. 108, 8, p. 2234-2239 6 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network
Martin, K. A., Lancki, N., Kreuziger, L. B., Li, C., Eyster, M. E., Sanfilippo, K., Woller, S. C. & Rosovsky, R. P., Sep 2023, In: Thrombosis research. 229, p. 146-148 3 p.Research output: Contribution to journal › Letter › peer-review
-
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
Li, Y., Xu-Monette, Z. Y., Abramson, J., Sohani, A. R., Bhagat, G., Tzankov, A., Visco, C., Zhang, S., Dybkaer, K., Pan, Z., Xu, M., Tam, W., Zu, Y., Hsi, E. D., Hagemeister, F. B., Go, H., van Krieken, J. H., Winter, J. N., Ponzoni, M. & Ferreri, A. J. M. & 5 others, , Apr 11 2023, In: Blood Advances. 7, 7, p. 1308-1311 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access7 Scopus citations -
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
Khan, I., Kaempf, A., Raghuwanshi, S., Chesnokov, M., Zhang, X., Wang, Z., Domling, A., Tyner, J. W., Camacho, C. & Gartel, A. L., Dec 2023, In: Blood cancer journal. 13, 1, 128.Research output: Contribution to journal › Letter › peer-review
Open Access4 Scopus citations -
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study
Annunzio, K., Grover, N. S., Welkie, R. L., Torka, P., Watkins, M. P., Anampa-Guzmán, A., Tavakkoli, M., Oh, T. S., Reves, H., Jones, D., Hanel, W., Christian, B., Geethakumari, P. R., Karmali, R., Barta, S. K., Bartlett, N. L., Olszewski, A. J. & Epperla, N., 2023, In: Blood Advances. 7, 22, p. 6839-6843 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study
Epperla, N., Welkie, R. L., Torka, P., Shouse, G., Karmali, R., Shea, L., Anampa-Guzmán, A., Oh, T. S., Reaves, H., Tavakkoli, M., Lindsey, K., Greenwell, I. B., Hansinger, E., Thomas, C., Chowdhury, S. M., Annunzio, K., Christian, B., Barta, S. K., Geethakumari, P. R. & Bartlett, N. L. & 3 others, , Dec 2023, In: Journal of Hematology and Oncology. 16, 1, 49.Research output: Contribution to journal › Letter › peer-review
Open Access9 Scopus citations -
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
Epperla, N., Feng, L., Shah, N. N., Fitzgerald, L., Shah, H., Stephens, D. M., Lee, C. J., Ollila, T., Shouse, G., Danilov, A. V., David, K. A., Torka, P., Hashmi, H., Hess, B., Barta, S. K., Romancik, J. T., Cohen, J. B., Annunzio, K., Kittai, A. S. & Reneau, J. & 9 others, , Dec 2023, In: Journal of Hematology and Oncology. 16, 1, 111.Research output: Contribution to journal › Letter › peer-review
Open Access11 Scopus citations -
Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome: Findings From a Phase 1a Trial
Derebail, V. K., Zhu, J., Crawford, M. L., Garnier, J. R., Martin, K. A., Skinner, S., Patel, T., Froment, A., Sketch, M. R., Szeto, A. H., Patel, S. M., Torrice, C. D., Tiefenbacher, S., Adcock, D. M., Grant, R. P., Key, N. S. & Crona, D. J., Mar 2023, In: American Journal of Kidney Diseases. 81, 3, p. 373-376 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access3 Scopus citations -
Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma
Wallace, D. S., Rowland, C., Hill, B. T., Baran, A. M., Casulo, C., Reagan, P. M., Winter, A., Karmali, R., Winter, J. N., Gordon, L. I., Bui, A., Sportelli, P., Miskin, H. P., Weiss, M. S., Friedberg, J. W., Ma, S. & Barr, P. M., 2023, In: Leukemia and Lymphoma. 64, 9, p. 1579-1582 4 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Postibrutinib relapse outcomes for patients with marginal zone lymphoma
Epperla, N., Zhao, Q., Chowdhury, S. M., Shea, L., Moyo, T. K., Reddy, N., Sheets, J., Weiner, D. M., Geethakumari, P. R., Kandarpa, M., Bruno, X. J., Thomas, C., Churnetski, M. C., Hsu, A., Zurbriggen, L., Tan, X. W. C., Lindsey, K., Maakaron, J., Caimi, P. F. & Torka, P. & 26 others, , Jan 10 2023, In: Blood Advances. 7, 1, p. 88-91 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Reply to Bareille et al. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on “Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11, 860”
Volod, O., Bunch, C. M., Miller, J., Moore, E. E., Moore, H. B., Kwaan, H. C., Patel, S. S., Wiarda, G., Aboukhaled, M., Thomas, S. G., Fulkerson, D., Erdman, L., Tincher, A. & Walsh, M. M., Jan 2023, In: Journal of Clinical Medicine. 12, 2, 478.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Reply to O. Devlin et al
Chandra, S., Choi, J. S. & Sosman, J. A., Apr 20 2023, In: Journal of Clinical Oncology. 41, 12, p. 2296-2297 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Richter transformation to aggressive plasmablastic neoplasm related to selection of a BTK-mutated clone in a patient with CLL/SLL treated by ibrutinib
Aqil, B., Kaur, A., Ramos, J., Sukhanova, M., Ma, S., Gao, J., Lu, X., Chen, Y. H. & Chen, Q., 2023, In: Leukemia and Lymphoma. 64, 1, p. 242-245 4 p.Research output: Contribution to journal › Letter › peer-review
3 Scopus citations -
Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study
DiNardo, C. D., De Botton, S., Pollyea, D. A., Stone, R. M., Altman, J. K., Fathi, A. T., Limsakun, T., Liang, M., Choe, S., Hossain, M., Tron, A. E., Meng, Q., Kapsalis, S. M., Pandya, S. S. & Stein, E. M., Sep 2023, In: American Journal of Hematology. 98, 9, p. E233-E236Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
2022
A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia
Vasu, S., Altman, J. K., Uy, G. L., Tallman, M. S., Gojo, I., Lozanski, G., Burkard, U., Osswald, A., James, P., Rüter, B. & Blum, W., Mar 2022, In: Haematologica. 107, 3, p. 770-773 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access10 Scopus citations -
Barriers and facilitators to preventing venous thromboembolism in oncology practice
Martin, K. A., Lyleroehr, M. J. & Cameron, K. A., Dec 2022, In: Thrombosis research. 220, p. 21-23 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access5 Scopus citations -
Classification of rare pediatric myeloid neoplasia—Quo vadis?
Niemeyer, C. M., Rudelius, M., Shimamura, A., Flotho, C., Hasle, H., Stieglitz, E., Strahm, B., Godley, L. A., Weinberg, O. K., Orazi, A. & Calvo, K. R., Dec 2022, In: Leukemia. 36, 12, p. 2947-2948 2 p.Research output: Contribution to journal › Letter › peer-review
6 Scopus citations -
Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations
NISC Comparative Sequencing Program, Aug 9 2022, In: Blood Advances. 6, 15, p. 4357-4359 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access16 Scopus citations -
Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10
Behdad, A., Schipma, M. J., Ma, S., Chen, Y. H. & Chen, Q. C., 2022, In: Leukemia and Lymphoma. 63, 13, p. 3222-3226 5 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera
Tremblay, D., Srisuwananukorn, A., Ronner, L., Podoltsev, N., Gotlib, J., Heaney, M. L., Kuykendall, A., O'Connell, C. L., Shammo, J. M., Fleischman, A., Mesa, R., Yacoub, A., Hoffman, R., Moshier, E., Zubizarreta, N. & Mascarenhas, J., Jun 11 2022, In: HemaSphere. 6, 6, p. E721Research output: Contribution to journal › Letter › peer-review
Open Access9 Scopus citations -
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
Rapaport, F., Seier, K., Neelamraju, Y., Hassane, D., Baslan, T., Gildea, D. T., Haddox, S., Lee, T., Murdock, H. M., Sheridan, C., Thurmond, A., Wang, L., Carroll, M., Cripe, L. D., Fernandez, H., Mason, C. E., Paietta, E., Roboz, G. J., Sun, Z. & Tallman, M. S. & 6 others, , Sep 2022, In: Blood cancer journal. 12, 9, 137.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis
Cavazos, K., Eswaran, S., Maidlow, C., Keklik Karadag, F., Idilman, R., Idilman, I., Miller, I., Shammo, J., Reau, N. & Ustun, C., Oct 25 2022, In: Blood Advances. 6, 20, p. 5630-5633 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
King, A. C., Weis, T. M., Derkach, A., Ball, S., Pandey, M., Mauro, M. J., Goldberg, A. D., Stahl, M., Famulare, C., Tallman, M. S., Wang, E. S., Kuykendall, A. T. & Rampal, R. K., Jan 1 2022, In: American Journal of Hematology. 97, 1, p. E7-E10Research output: Contribution to journal › Letter › peer-review
Open Access18 Scopus citations -
Non-leukemic presentation of acute promyelocytic leukemia as a testicular mass with associated non-canonical FLT3 mutation
Aqil, B., Gao, J., Rahn, H. R., Sukhanova, M., Lu, X., Altman, J., Jennings, L., Chen, Q. & Chen, Y. H., 2022, In: Leukemia and Lymphoma. 63, 14, p. 3493-3496 4 p.Research output: Contribution to journal › Letter › peer-review
-
Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival
Badar, T., Atallah, E., Shallis, R. M., Goldberg, A. D., Patel, A., Abaza, Y., Bewersdorf, J. P., Saliba, A. N., Correia, G. S. D. C., Murthy, G., Duvall, A., Burkart, M., Stahl, M., Liu, Y., Dinner, S., Palmisiano, N., Litzow, M. R. & Foran, J. M., Jul 2022, In: American Journal of Hematology. 97, 7, p. E232-E235Research output: Contribution to journal › Letter › peer-review
Open Access29 Scopus citations -
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
Epperla, N., Zhao, Q., Chowdhury, S. M., Shea, L., Moyo, T. K., Reddy, N., Sheets, J., Weiner, D. M., Geethakumari, P. R., Kandarpa, M., Bruno, X. J., Thomas, C., Churnetski, M. C., Hsu, A., Zurbriggen, L., Tan, C., Lindsey, K., Maakaron, J., Caimi, P. F. & Torka, P. & 25 others, , Dec 2022, In: Journal of Hematology and Oncology. 15, 1, 96.Research output: Contribution to journal › Letter › peer-review
Open Access4 Scopus citations -
Pulmonary embolism–related mortality during the COVID-19 pandemic: Data from the United States
Martin, K. A., Harrington, K., Huang, X. & Khan, S. S., Nov 2022, In: Research and Practice in Thrombosis and Haemostasis. 6, 8, e12845.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Response to “The WHO classification of haematolymphoid tumours” (Editorial)
Swerdlow, S. H., Campo, E., Arber, D. A., Cazzola, M., Cook, J. R., Döhner, H., Dreyling, M., Hasserjian, R. P., Jaffe, E. S., Orazi, A., Quintanilla-Martinez, L., Scott, D. W., Tefferi, A., Winter, J. N. & Zelenetz, A. D., Nov 2022, In: Leukemia. 36, 11, p. 2748-2749 2 p.Research output: Contribution to journal › Letter › peer-review
12 Scopus citations -
The antagonistic duality of NPM1 mutations in AML
Khan, I. & Gartel, A. L., Jul 12 2022, In: Blood Advances. 6, 13, p. 4028-4030 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
2021
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Zeidner, J. F., Lin, T. L., Vigil, C. E., Fine, G., Yair Levy, M., Nazha, A., Esteve, J., Lee, D. J., Yee, K., Dalovisio, A., Wang, E. S., Bergua Burgues, J. M., Schriber, J., Litzow, M. R., Frankfurt, O., Castillo, T. B. D., Bhatt, V. R., Bhatnagar, B., Mehta, P. & Dillon, R. & 5 others, , Oct 2021, In: Blood cancer journal. 11, 10, 175.Research output: Contribution to journal › Letter › peer-review
Open Access3 Scopus citations -
A Randomized Clinical Trial on Anterior Approach vs Conventional Hepatectomy for Resection of Colorectal Liver Metastasis - To Terminate or Not to Terminate the Study
Gupta, D., Lee, J. J. & Lin, A. Y., Sep 2021, In: JAMA surgery. 156, 9, p. 893-894 2 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
BET inhibitors enhance embryonic and fetal globin expression in erythroleukemia cell lines
Cao, J. Z., Bigelow, K., Wickrema, A. & Godley, L. A., Dec 2021, In: Haematologica. 106, 12, p. 3223-3227 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes
St. Martin, E. C., Ferrer, A., Wudhikarn, K., Mangaonkar, A., Hogan, W., Tefferi, A., Gangat, N., Lasho, T., Altman, J. K., Godley, L. A. & Patnaik, M. M., Sep 1 2021, In: American Journal of Hematology. 96, 9, p. E327-E330Research output: Contribution to journal › Letter › peer-review
Open Access7 Scopus citations -
Combination Doxorubicin and Pembrolizumab in Patients with Advanced Anthracycline-Naive Sarcoma - Reply
Wagner, M. J., Cranmer, L. D. & Pollack, S. M., Mar 2021, In: JAMA Oncology. 7, 3, p. 465-466 2 p.Research output: Contribution to journal › Letter › peer-review
-
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Mehta, J., Jun 10 2021, In: The New England journal of medicine. 384, 23, p. e91Research output: Contribution to journal › Letter › peer-review
11 Scopus citations -
Fixing the Leaky Pipeline: Redefining Physician-Scientist Efforts to Fit the Needs of the New Normal
Lin, A. Y., Dec 1 2021, In: Academic Medicine. 96, 12, p. 1628-1629 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Germline variants drive myelodysplastic syndrome in young adults
Feurstein, S., Churpek, J. E., Walsh, T., Keel, S., Hakkarainen, M., Schroeder, T., Germing, U., Geyh, S., Heuser, M., Thol, F., Pohlkamp, C., Haferlach, T., Gao, J., Owen, C., Goehring, G., Schlegelberger, B., Verma, D., Krause, D. S., Gao, G. & Cronin, T. & 15 others, , Aug 2021, In: Leukemia. 35, 8, p. 2439-2444 6 p.Research output: Contribution to journal › Letter › peer-review
Open Access48 Scopus citations -
Mast cell sarcoma transdifferentiated from clonally-related T-lymphoblastic leukemia upon acquisition of TP53 mutation and genetic complexity
Gao, J., Fu, L., Lu, X., Sukhanova, M., Frankfurt, O., Mohtashamian, A., Chadburn, A., Jennings, L., Aqil, B., Chen, Q. & Chen, Y. H., 2021, In: Leukemia and Lymphoma. 62, 13, p. 3304-3307 4 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
More on the Source of D-Dimer in COVID-19
Kwaan, H. C. & Mazar, A. P., Jun 25 2021, In: Thrombosis and Haemostasis. 122, 1, p. 158-159 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Olaparib in Metastatic Castration-Resistant Prostate Cancer. Reply
Hussain, M., Desai, C. & de Bono, J., Mar 25 2021, In: The New England journal of medicine. 384, 12, p. 1175-1176 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024
de Bono, J., Hussain, M. & Kang, J., Mar 2021, In: European urology. 79, 3, p. e83-e84Research output: Contribution to journal › Letter › peer-review
-
Reply to S. Sorscher
Johnston, S. R. D. & Gradishar, W. J., Apr 1 2021, In: Journal of Clinical Oncology. 39, 10, p. 1188 1 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Reply to T. Shimoi et al and Y. Shimanuki et al
Mayer, I. A., Zhao, F., Arteaga, C. L., Symmans, W. F., Park, B. H., Burnette, B. L., Tevaarwerk, A. J., Garcia, S. F., Smith, K. L., Makower, D. F., Block, M., Morley, K. A., Jani, C. R., Mescher, C., Dewani, S. J., Tawfik, B., Flaum, L. E., Mayer, E. L., Sikov, W. M. & Rodler, E. T. & 5 others, , Nov 1 2021, In: Journal of Clinical Oncology. 39, 31, p. 3522-3523 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access